Skip to main content


Page 33 of 35

  1. Continual discoveries on non-coding RNA (ncRNA) have changed the landscape of human genetics and molecular biology. Over the past ten years it has become clear that ncRNAs are involved in many physiological ce...

    Authors: Marco Galasso, Maria Elena Sana and Stefano Volinia
    Citation: Genome Medicine 2010 2:12
  2. Evidence for genetic contribution to complex diseases is described by recurrence risks to relatives of diseased individuals. Genome-wide association studies allow a description of the genetics of the same dise...

    Authors: Naomi R Wray and Michael E Goddard
    Citation: Genome Medicine 2010 2:10
  3. Skeletal muscle insulin resistance (IR) is considered a critical component of type II diabetes, yet to date IR has evaded characterization at the global gene expression level in humans. MicroRNAs (miRNAs) are ...

    Authors: Iain J Gallagher, Camilla Scheele, Pernille Keller, Anders R Nielsen, Judit Remenyi, Christian P Fischer, Karim Roder, John Babraj, Claes Wahlestedt, Gyorgy Hutvagner, Bente K Pedersen and James A Timmons
    Citation: Genome Medicine 2010 2:9
  4. Ewing's sarcoma family tumors are a good example of how genome research has advanced our understanding of the molecular pathogenesis of an otherwise enigmatic disease. This group of embryonal bone tumors is ch...

    Authors: Heinrich Kovar
    Citation: Genome Medicine 2010 2:8
  5. Hepatitis C is a viral disease transmitted principally by blood, which affects millions of people worldwide. A significant proportion of those affected develop severe liver disease as a result. Only a fraction...

    Authors: David G Nathan and Stuart H Orkin
    Citation: Genome Medicine 2010 2:4
  6. Specific language impairment (SLI) is defined as an unexpected and persistent impairment in language ability despite adequate opportunity and intelligence and in the absence of any explanatory medical conditio...

    Authors: Dianne F Newbury, Simon E Fisher and Anthony P Monaco
    Citation: Genome Medicine 2010 2:6
  7. Primary biliary cirrhosis (PBC) is an autoimmune hepatobiliary disease characterized by immune-mediated injury of small and medium-sized bile ducts, eventually leading to liver cirrhosis. Several studies have ...

    Authors: Carlo Selmi, Natalie J Torok, Andrea Affronti and M Eric Gershwin
    Citation: Genome Medicine 2010 2:5
  8. Genome-wide association studies have detected dozens of variants underlying complex diseases, although it is uncertain how often these discoveries will translate into clinically useful predictors. Here, to imp...

    Authors: Douglas M Ruderfer, Joshua Korn and Shaun M Purcell
    Citation: Genome Medicine 2010 2:2
  9. Cancer cachexia is a multi-organ tissue wasting syndrome that contributes to morbidity and mortality in many cancer patients. Skeletal muscle loss represents an established key feature yet there is no molecula...

    Authors: Nathan A Stephens, Iain J Gallagher, Olav Rooyackers, Richard J Skipworth, Ben H Tan, Troels Marstrand, James A Ross, Denis C Guttridge, Lars Lundell, Kenneth C Fearon and James A Timmons
    Citation: Genome Medicine 2010 2:1
  10. Although statins are generally well tolerated, the most common adverse drug reaction from statin therapy is myopathy. This article reviews the current pharmacogenomic knowledge of statin-induced myopathy. Furt...

    Authors: Bas JM Peters, Olaf H Klungel, Frank L Visseren, Anthonius de Boer and Anke-Hilse Maitland-van der Zee
    Citation: Genome Medicine 2009 1:120
  11. Public health preparedness requires effective surveillance of and rapid response to infectious disease outbreaks. Inclusion of research activities within the outbreak setting provides important opportunities t...

    Authors: Nicole F Dowling, Marta Gwinn and Alison Mawle
    Citation: Genome Medicine 2009 1:119
  12. Women's Health Initiative randomized trials of postmenopausal hormone therapy reported intervention effects on several clinical outcomes, with some important differences between estrogen alone and estrogen plu...

    Authors: Sharon J Pitteri, Samir M Hanash, Aaron Aragaki, Lynn M Amon, Lin Chen, Tina Busald Buson, Sophie Paczesny, Hiroyuki Katayama, Hong Wang, Melissa M Johnson, Qing Zhang, Martin McIntosh, Pei Wang, Charles Kooperberg, Jacques E Rossouw, Rebecca D Jackson…
    Citation: Genome Medicine 2009 1:121
  13. The peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors and members of the nuclear receptor superfamily. The PPAR family consists of three members: PPARα, PPARγ, and ...

    Authors: Lee D Roberts, David G Hassall, Deborah A Winegar, John N Haselden, Andrew W Nicholls and Julian L Griffin
    Citation: Genome Medicine 2009 1:115
  14. Chronic obstructive pulmonary disease (COPD) is a common problem worldwide, and it is recognized that the term encompasses overlapping sub-phenotypes of disease. The development of a sub-phenotype may be deter...

    Authors: Alice M Wood, See Ling Tan and Robert A Stockley
    Citation: Genome Medicine 2009 1:112
  15. Genomic data often persist far beyond the initial study in which they were generated. But the true value of the data is tied to their being both used and useful, and the usefulness of the data relies intimatel...

    Authors: John Quackenbush
    Citation: Genome Medicine 2009 1:111
  16. Although the literature concerning statistical testing for genotype-phenotype association in family-based and population-based studies is very extensive, until recently the sex chromosomes have received little...

    Authors: David G Clayton
    Citation: Genome Medicine 2009 1:110
  17. A function for the microRNA (miRNA) pathway in vascular development and angiogenesis has been firmly established. miRNAs with selective expression in the vasculature are attractive as possible targets in miRNA...

    Authors: Erik Larsson, Peder Fredlund Fuchs, Johan Heldin, Irmeli Barkefors, Cecilia Bondjers, Guillem Genové, Christelle Arrondel, Pär Gerwins, Christine Kurschat, Bernhard Schermer, Thomas Benzing, Scott J Harvey, Johan Kreuger and Per Lindahl
    Citation: Genome Medicine 2009 1:108
  18. The inflammatory bowel diseases, Crohn's disease and ulcerative colitis, pose a fascinating challenge to specialists in gastroenterology, infectious diseases, immunology and genetics and an often crushing burd...

    Authors: David G Nathan and Stuart H Orkin
    Citation: Genome Medicine 2009 1:103
  19. Technological advances have enabled a better characterization of all the genetic alterations in tumors. A picture that emerges is that tumor cells are much more genetically heterogeneous than originally expect...

    Authors: Sandro J de Souza, Beatriz Stransky and Anamaria A Camargo
    Citation: Genome Medicine 2009 1:101
  20. Genome-wide association studies are the most comprehensive and straightforward approach to teasing out the identity of genetic polymorphisms associated with any given disease or characteristic. With the availa...

    Authors: Bruce N Cronstein
    Citation: Genome Medicine 2009 1:98
  21. Transposable elements (TEs) have been consistently underestimated in their contribution to genetic instability and human disease. TEs can cause human disease by creating insertional mutations in genes, and als...

    Authors: Victoria P Belancio, Prescott L Deininger and Astrid M Roy-Engel
    Citation: Genome Medicine 2009 1:97
  22. Mitochondrial disorders can originate from mutations in one of many nuclear genes controlling the organelle function or in the mitochondrial genome (mitochondrial DNA (mtDNA)). The large numbers of potential c...

    Authors: Valeria Vasta, Sarah B Ng, Emily H Turner, Jay Shendure and Si Houn Hahn
    Citation: Genome Medicine 2009 1:100
  23. In June 2009, the Science and Technology Committee of the UK House of Lords published a report on genomic medicine, based on expert evidence collected over an 18-month period. Crucially, the report signaled th...

    Authors: Hilary Burton, Caroline F Wright and Ron Zimmern
    Citation: Genome Medicine 2009 1:93
  24. Systems biology has matured considerably as a discipline over the last decade, yet some of the key challenges separating current research efforts in systems biology and clinically useful results are only now b...

    Authors: Gilles Clermont, Charles Auffray, Yves Moreau, David M Rocke, Daniel Dalevi, Devdatt Dubhashi, Dana R Marshall, Peter Raasch, Frank Dehne, Paolo Provero, Jesper Tegner, Bruce J Aronow, Michael A Langston and Mikael Benson
    Citation: Genome Medicine 2009 1:88
  25. Translation of research findings into clinical practice is an important aspect of medical progress. Even for the early stages of genomics, research aiming to deepen understandings of underlying mechanisms of d...

    Authors: Naomi Hawkins, Jantina de Vries, Paula Boddington, Jane Kaye and Catherine Heeney
    Citation: Genome Medicine 2009 1:87
  26. Gene patents have generally not impeded biomedical research, but some problems that arise in genetic diagnostics can be attributed to exclusively licensed gene patents. Gene patents for therapeutics have often...

    Authors: Subhashini Chandrasekharan and Robert Cook-Deegan
    Citation: Genome Medicine 2009 1:92
  27. A major transition in human population structure is currently under way, moving from a historical metapopulation, comprising small and mainly rural endogamous communities, to large and increasingly panmictic u...

    Authors: Harry Campbell, Igor Rudan, Alan H Bittles and Alan F Wright
    Citation: Genome Medicine 2009 1:91
  28. Recent studies have demonstrated that network approaches are highly appropriate tools for understanding the extreme complexity of the aging process. Moreover, the generality of the network concept helps to def...

    Authors: Gábor I Simkó, Dávid Gyurkó, Dániel V Veres, Tibor Nánási and Peter Csermely
    Citation: Genome Medicine 2009 1:90
  29. From the point of view of genome medicine, Barack Obama has made two vital policy decisions: he has chosen a new director of the National Institutes of Health, and his proposed change in United States healthca...

    Authors: David G Nathan and Stuart H Orkin
    Citation: Genome Medicine 2009 1:86
  • Editorial Board
  • Editorial Team
  • Call for EBMs
  • Call for papers
  • Sign up for article alerts and news from this journal
  • Manuscript editing services
  • Contact us
  • Announcements

    C19 Rapid Review initiative

    Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here

    Submissions from medRxiv 

    Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.

    Portable peer review

    To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.

    COVID-19 submissions

    In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.

Annual Journal Metrics

  • 2022 Citation Impact
    12.3 - 2-year Impact Factor
    13.8 - 5-year Impact Factor
    2.422 - SNIP (Source Normalized Impact per Paper)
    4.851 - SJR (SCImago Journal Rank)

    2022 Speed
    64 days submission to first editorial decision for all manuscripts (Median)
    212 days submission to accept (Median)

    2022 Usage 
    14,220 Altmetric mentions